These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 27720936)
61. MiR-645 regulates the proliferation and apoptosis of diffuse large B-cell lymphoma by targeting DACH1. Wang R; Shen J; Su N; Wang Q; Zhang M; Liu C Hum Cell; 2020 Oct; 33(4):1091-1098. PubMed ID: 32529465 [TBL] [Abstract][Full Text] [Related]
62. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. Lu X; Nechushtan H; Ding F; Rosado MF; Singal R; Alizadeh AA; Lossos IS Blood; 2005 Apr; 105(7):2924-32. PubMed ID: 15591113 [TBL] [Abstract][Full Text] [Related]
63. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646 [TBL] [Abstract][Full Text] [Related]
64. Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma. Xu W; Berning P; Lenz G Blood; 2021 Sep; 138(13):1110-1119. PubMed ID: 34320160 [TBL] [Abstract][Full Text] [Related]
65. Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma. Yang JM; Jang JY; Jeon YK; Paik JH J Transl Med; 2018 Jun; 16(1):162. PubMed ID: 29890998 [TBL] [Abstract][Full Text] [Related]
66. SHP-1 requires inhibitory co-receptors to down-modulate B cell antigen receptor-mediated phosphorylation of cellular substrates. Adachi T; Wienands J; Wakabayashi C; Yakura H; Reth M; Tsubata T J Biol Chem; 2001 Jul; 276(28):26648-55. PubMed ID: 11356834 [TBL] [Abstract][Full Text] [Related]
67. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma. Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038 [TBL] [Abstract][Full Text] [Related]
68. Bortezomib inhibited the progression of diffuse large B-cell lymphoma via targeting miR-198. Wang R; Shen J; Wang Q; Zhang M Biomed Pharmacother; 2018 Dec; 108():43-49. PubMed ID: 30216798 [TBL] [Abstract][Full Text] [Related]
69. DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma. Schmid CA; Robinson MD; Scheifinger NA; Müller S; Cogliatti S; Tzankov A; Müller A J Exp Med; 2015 May; 212(5):775-92. PubMed ID: 25847947 [TBL] [Abstract][Full Text] [Related]
70. [Expression of MiRNA-21 in diffuse large B cell lymphoma and its significance]. Song GQ; Gu L; He BS; Pan YQ; Wang SK Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1603-9. PubMed ID: 25543482 [TBL] [Abstract][Full Text] [Related]
71. BTK kinase activity is dispensable for the survival of diffuse large B-cell lymphoma. Yuan H; Zhu Y; Cheng Y; Hou J; Jin F; Li M; Jia W; Cheng Z; Xing H; Liu M; Han T J Biol Chem; 2022 Nov; 298(11):102555. PubMed ID: 36183831 [TBL] [Abstract][Full Text] [Related]
72. MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma. Zhu FQ; Zeng L; Tang N; Tang YP; Zhou BP; Li FF; Wu WG; Zeng XB; Peng SS Oncol Res; 2016 Oct; 24(6):415-427. PubMed ID: 28281962 [TBL] [Abstract][Full Text] [Related]
73. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Musilova K; Mraz M Leukemia; 2015 May; 29(5):1004-17. PubMed ID: 25541152 [TBL] [Abstract][Full Text] [Related]
74. Regulation of the MIR155 host gene in physiological and pathological processes. Elton TS; Selemon H; Elton SM; Parinandi NL Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696 [TBL] [Abstract][Full Text] [Related]
75. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC. Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550 [TBL] [Abstract][Full Text] [Related]
76. Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin. Sun N; Wang CY; Sun YQ; Ruan YJ; Huang YY; Su T; Zhou XH; Huang H; Guo WJ; He MQ; Yao RX; Lin XJ Biomed Pharmacother; 2018 Oct; 106():267-274. PubMed ID: 29966970 [TBL] [Abstract][Full Text] [Related]
77. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells. Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849 [TBL] [Abstract][Full Text] [Related]
78. MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-β1/SMAD5 signaling module. Jiang D; Aguiar RC Blood; 2014 Jan; 123(1):86-93. PubMed ID: 24136167 [TBL] [Abstract][Full Text] [Related]
79. Mercury alters endogenous phosphorylation profiles of SYK in murine B cells. Caruso JA; Carruthers N; Shin N; Gill R; Stemmer PM; Rosenspire A BMC Immunol; 2017 Jul; 18(1):37. PubMed ID: 28716125 [TBL] [Abstract][Full Text] [Related]
80. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma. Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]